Evidence map›Paper›PMID 37503586›Full record

ArticleCurrent oncology (Toronto, Ont.)2023

Myeloproliferative Neoplasm Driven by

Samuele Renzi, Fatimah Algawahmed, Scott Davidson, Karin P S Langenberg, Fabio Fuligni, Salah Ali, Nathaniel Anderson, Ledia Brunga, Jack Bartram, Mohamed Abdelhaleem and 8 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Samuele RenziDivision of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON M4B 1B3, Canada.
Fatimah AlgawahmedLaboratory Medicine Program, University Health Network, Toronto, ON M5G 2M9, Canada.
Scott DavidsonProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Karin P S LangenbergPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Fabio FuligniProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Salah AliDepartment of Pediatric Haematology and Bone Marrow Transplant, Leeds Teaching Hospitals, Leeds LS9 7TF, UK.ORCID 0000-0003-3705-4064
Nathaniel AndersonProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Ledia BrungaProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Jack BartramDepartment of Hematology, Great Ormond Street Hospital, London WC1N 3JH, UK.ORCID 0000-0003-1573-2506
Mohamed AbdelhaleemDepartment of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Ahmed NaqviDivision of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON M4B 1B3, Canada.
Kassa BeimnetDepartment of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Andre SchuhDepartment of Haematology, Princess Margaret Hospital, Toronto, ON M5G 2C1, Canada.
Anne TierensLaboratory Medicine Program, University Health Network, Toronto, ON M5G 2M9, Canada.
David MalkinDivision of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON M4B 1B3, Canada.
Adam ShlienProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Mary ShagoDepartment of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Anita VillaniDivision of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON M4B 1B3, Canada.
Hospital for Sick Children · CAUniversity of Toronto · CAUniversity Health Network · CAGreat Ormond Street Hospital · GBLeeds Teaching Hospitals NHS Trust · GBPrincess Margaret Cancer Centre · CAPrincess Máxima Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Burkitt LymphomaLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentHumansImatinib MesylateIn Situ Hybridization, FluorescenceMaleProtein-Tyrosine KinasesImatinib MesylateProtein-Tyrosine Kinasesmyeloproliferative syndromeoncologypediatric malignancies

Identifiers

PMID37503586
PMCPMC10378670
OpenAlexW4381660968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.